KalVista Pharmaceuticals Inc (NASDAQ:KALV), a pharmaceutical company focused on the discovery, development, and commercialization of small molecule protease inhibitors for diseases with significant unmet need, has reported an insider sell according to a recent SEC filing.
Read full NASCAR article on Yahoo Sports
Read all NASCAR articles